Boston Trust Walden’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$216K Sell
485
-125
-20% -$55.7K ﹤0.01% 368
2025
Q1
$296K Sell
610
-200
-25% -$97K ﹤0.01% 348
2024
Q4
$326K Sell
810
-150
-16% -$60.4K ﹤0.01% 342
2024
Q3
$446K Sell
960
-150
-14% -$69.8K ﹤0.01% 324
2024
Q2
$520K Hold
1,110
﹤0.01% 316
2024
Q1
$464K Hold
1,110
﹤0.01% 323
2023
Q4
$452K Hold
1,110
﹤0.01% 318
2023
Q3
$386K Hold
1,110
﹤0.01% 318
2023
Q2
$391K Hold
1,110
﹤0.01% 320
2023
Q1
$350K Hold
1,110
﹤0.01% 328
2022
Q4
$321K Hold
1,110
﹤0.01% 335
2022
Q3
$321K Hold
1,110
﹤0.01% 325
2022
Q2
$313K Sell
1,110
-90
-8% -$25.4K ﹤0.01% 331
2022
Q1
$313K Hold
1,200
﹤0.01% 344
2021
Q4
$264K Sell
1,200
-33
-3% -$7.26K ﹤0.01% 368
2021
Q3
$224K Buy
1,233
+33
+3% +$6K ﹤0.01% 376
2021
Q2
$242K Hold
1,200
﹤0.01% 369
2021
Q1
$258K Hold
1,200
﹤0.01% 352
2020
Q4
$284K Sell
1,200
-308
-20% -$72.9K ﹤0.01% 348
2020
Q3
$410K Hold
1,508
0.01% 322
2020
Q2
$438K Hold
1,508
0.01% 318
2020
Q1
$359K Hold
1,508
0.01% 320
2019
Q4
$330K Hold
1,508
﹤0.01% 349
2019
Q3
$255K Hold
1,508
﹤0.01% 359
2019
Q2
$277K Hold
1,508
﹤0.01% 356
2019
Q1
$277K Hold
1,508
﹤0.01% 359
2018
Q4
$250K Hold
1,508
﹤0.01% 358
2018
Q3
$291K Sell
1,508
-50
-3% -$9.65K ﹤0.01% 357
2018
Q2
$265K Hold
1,558
﹤0.01% 363
2018
Q1
$254K Sell
1,558
-625
-29% -$102K ﹤0.01% 368
2017
Q4
$327K Hold
2,183
﹤0.01% 353
2017
Q3
$332K Sell
2,183
-125
-5% -$19K 0.01% 352
2017
Q2
$297K Buy
+2,308
New +$297K ﹤0.01% 355